Mereo BioPharma Group plc Quarterly Operating Lease, Payments in USD from Q1 2023 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Mereo BioPharma Group plc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2023 to Q4 2024.
  • Mereo BioPharma Group plc Operating Lease, Payments for the quarter ending December 31, 2024 was $195K, a 12.2% decline year-over-year.
  • Mereo BioPharma Group plc Operating Lease, Payments for the twelve months ending December 31, 2024 was $780K, a 2.77% increase year-over-year.
  • Mereo BioPharma Group plc annual Operating Lease, Payments for 2024 was $780K, a 2.77% increase from 2023.
  • Mereo BioPharma Group plc annual Operating Lease, Payments for 2023 was $759K, a 34.2% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $780K $195K -$27K -12.2% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-26
Q3 2024 $807K $198K +$5K +2.59% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $802K $193K +$2K +1.05% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $800K $194K +$41K +26.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $759K $222K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-26
Q3 2023 $193K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $191K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $153K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.